World's Best Scientists 2026 revealed!
Marco Matucci-Cerinic

Marco Matucci-Cerinic

D-Index & Metrics

Medicine

D-Index
121
Citations
68566
World Ranking
3556
National Ranking
103

Marco Matucci-Cerinic publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Marco Matucci-Cerinic sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 1,307 publications — 98th percentile

98% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Marco Matucci-Cerinic D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Marco Matucci-Cerinic sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 121 D-Index — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Marco Matucci-Cerinic is affiliated with the University of Florence in Italy. Their research work primarily spans the field of Medicine, with a strong focus on Rheumatology, Pulmonary and Respiratory Medicine, and Dermatology, among other subfields.

The main subfields of study for this scientist include:

  • Pathology and Forensic Medicine
  • Pulmonary and Respiratory Medicine
  • Rheumatology
  • Dermatology
  • Epidemiology

Their work covers several major topics such as:

  • Systemic Sclerosis and Related Diseases
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Dermatologic Treatments and Research
  • Inflammatory Myopathies and Dermatomyositis
  • Mast cells and histamine
  • Rheumatoid Arthritis Research and Therapies
  • Autoimmune and Inflammatory Disorders Research

Marco Matucci-Cerinic has collaborated frequently with several co-authors including:

  • Cosimo Bruni
  • Silvia Bellando-Randone
  • Serena Guiducci
  • Lorenzo Dagna
  • Corrado Campochiaro

The scientist has published extensively in well-known academic journals. The most frequent publication venues include:

  • Annals of the Rheumatic Diseases
  • Lara D. Veeken
  • The Lancet Rheumatology
  • Therapeutic Advances in Musculoskeletal Disease
  • Seminars in Arthritis and Rheumatism

Notable recent papers authored or co-authored by Marco Matucci-Cerinic cover a range of topics related to systemic sclerosis, immune response, and rheumatology. These include:

  • Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial, 2020, The Lancet Respiratory Medicine
  • COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs, 2020, TURKISH JOURNAL OF MEDICAL SCIENCES
  • Raynaud phenomenon and digital ulcers in systemic sclerosis, 2020, Nature Reviews Rheumatology
  • EULAR recommendations for the treatment of systemic sclerosis: 2023 update, 2024, Annals of the Rheumatic Diseases
  • Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS), 2021, The Lancet Rheumatology

Marco Matucci-Cerinic has contributed to scholarly books as well, with publications through Frontiers Media including the title:

  • Pulmonary Fibrosis: One Manifestation, Various Diseases, 2022

Best Publications

  • 2013 classification criteria for systemic sclerosis: An american college of rheumatology/European league against rheumatism collaborative initiative

    Frank Van Den Hoogen;Dinesh Khanna;Jaap Fransen;Sindhu R. Johnson

  • American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials

    David T. Felson;David T. Felson;Josef S. Smolen;George Wells;Bi Zhang

  • Update of EULAR recommendations for the treatment of systemic sclerosis

    Otylia Kowal-Bielecka;Jaap Fransen;Jerome Avouac;Mike Becker;Mike Becker

  • Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database

    U A Walker;A Tyndall;L Czirják;C Denton

  • Prevalence of fibromyalgia: a survey in five European countries.

    Jaime C. Branco;Bernard Bannwarth;Inmaculada Failde;Jordi Abello Carbonell

  • Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist.

    J. H. Korn;Maureen D Mayes;M. Matucci Cerinic;M. Rainisio

  • EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)

    O. Kowal-Bielecka;R. Landewé;J. Avouac;S. Chwiesko

  • Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis: A Randomized Clinical Trial

    J.M. van Laar;D. Farge;J.K. Sont;K. Naraghi

  • Accelerated Atherosclerosis in Autoimmune Rheumatic Diseases

    Yehuda Shoenfeld;Roberto Gerli;Andrea Doria;Eiji Matsuura

  • Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations.

    D. Aletaha;R.B. Landewe;T. Karonitsch;J. Bathon

  • Mapping and predicting mortality from systemic sclerosis

    Muriel Elhai;Christophe Meune;Marouane Boubaya;Jérôme Avouac

  • Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial.

    Dinesh Khanna;Celia J F Lin;Daniel E Furst;Jonathan Goldin

  • Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial

    Marco Matucci-Cerinic;Christopher P Denton;Daniel E Furst;Maureen D Mayes

  • Mortality in systemic sclerosis: An international meta-analysis of individual patient data

    John P.A. Ioannidis;John P.A. Ioannidis;Panayiotis G. Vlachoyiannopoulos;Anna Bettina Haidich;Thomas A. Medsger

  • Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis

    Dinesh Khanna;Daniel E. Furst;Philip J. Clements;Yannick Allanore

  • Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group

    Jérôme Avouac;J. Fransen;U. A. Walker;V. Riccieri

  • Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis

    X Mariette;M Matucci-Cerinic;K Pavelka;P Taylor

  • Review: evidence that systemic sclerosis is a vascular disease.

    Marco Matucci-Cerinic;Bashar Kahaleh;Fredrick M. Wigley

  • Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group

    Suzana Jordan;Jörg H W Distler;Britta Maurer;Dörte Huscher

  • COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs

    Abdurrahman Tufan;Aslihan Avanoğlu Güler;Marco Matucci-Cerinic

Frequent Co-Authors

Yannick Allanore
Yannick Allanore Université Paris Cité
Christopher P. Denton
Christopher P. Denton University College London
Oliver Distler
Oliver Distler University of Zurich
Daniel E. Furst
Daniel E. Furst University of California, Los Angeles
Dinesh Khanna
Dinesh Khanna University of Michigan–Ann Arbor
Ulf Müller-Ladner
Ulf Müller-Ladner University of Giessen
Paolo Airò
Paolo Airò University of Brescia
Janet E. Pope
Janet E. Pope University of Western Ontario
Gabriela Riemekasten
Gabriela Riemekasten University of Lübeck
Valeria Riccieri
Valeria Riccieri Sapienza University of Rome

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a future in Medicine doesn’t always mean attending a traditional medical school in the USA. There are many affordable online pathways that can lead to impactful careers in healthcare. For those interested in healthcare administration, several universities now offer some of the cheapest mha programs online healthcare. These options allow you to develop management and leadership skills without high tuition costs.

If you are a nurse aiming to advance your career, consider enrolling in one of the least expensive dnp programs. These programs can help you achieve the highest level of clinical nursing practice while studying flexibly online.

Pharmacists can also benefit from remote study by considering pharm d online programs. These are designed for busy professionals who wish to further their expertise and credentials without leaving the workforce.

Finally, as electronic medical records become more essential, the demand for skilled health IT professionals is increasing. A health information technology online degree prepares you to manage patient data and support healthcare delivery in diverse settings.

Best Scientists Citing Marco Matucci-Cerinic

Trending Scientists